期刊文献+

30例非典型脑膜瘤患者临床病理特征与预后分析 被引量:10

Clinicopathologic Features and Prognosis of Atypical Meningioma:A Report of 30 cases.
下载PDF
导出
摘要 目的探讨非典型脑膜瘤(WHO grade II)临床病理特征及其对生存期的影响。方法收集2001年1月至2007年12月在中山大学肿瘤医院手术治疗并经病理确诊的、有完整临床随访资料的病例30例非典型脑膜瘤,应用Kaplan-Meier法、log-rank检验和Cox回归模型对其性别、年龄、肿瘤大小、Ki-67阳性率、P53阳性率、手术切除程度以及术后放疗等7项临床和病理特征进行单因素和多因素生存分析。结果患者中位年龄47岁,其中男9例,女21例。中位随访时间62个月(22~110个月)。平均复发时间为65个月(56~74个月),2年和5年无复发生存率分别为89%和62%。单因素和Cox多因素预后分析发现Ki-67表达和肿瘤大小两因素对生存期的影响有统计学意义(P<0.05)。结论肿瘤体积大、Ki-67高表达的非典型脑膜瘤患者容易复发,术后要严密随访。 Objective To investigate the clinicopathologic features and the impact of these factors on the survival time of atypical meningiomas (AMs) ( WHO grade II). Methods A total of 30 definite cases of AMs with integrity clinical and follow-up information at the Cancer Center of Sun Yat-Sen Univercity between January 2001 and December 2007 were selected and seven factors including sex ,age ,tumor size,Ki-67 ,P53 ,resection degree and radiotherapy were analyzed by Kaplan-Meier method, log-rank analysis and Cox's proportional hazard regression model. Results The median age was 47 years and there were 9 men and 21 women. The median follow-up period was 62 months (range,22 -110 months). The mean period of recurrence was 65 months ( range,56 -74 months) , recurrence-free survival (RFS) of 2 years and 5 years was 89% and 62% respectively. Simple analysis and multivariate regression analyses Showed that Ki-67 and tumor size were the risk factors affecting survival time ( P 〈 0. 05 ). Conclusions AMs patients with large tumor size and high ex- pression of Ki-67 have high recurrent rate and they must be follow up frequently after therapy.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2009年第9期513-516,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 非典型脑膜瘤 临床病理特征 生存分析 Atypical meningioma Clinicopathologic Features Survival analysis
  • 相关文献

参考文献13

  • 1杨学军.解读《世界卫生组织中枢神经系统肿瘤分类(2007年)》[J].中国神经精神疾病杂志,2007,33(9):513-517. 被引量:115
  • 2Goyal L, Suh J, Mohan D, et al. Local control and overall survival in atypical meningioma: A retrospective study [ J ]. Int J Radiat Oncol Biol Phys, 2000, 46 ( 1 ) :57 - 61. 被引量:1
  • 3Kleihues P, Cavenee W. World Health Organization classification of tumors : Pathology and genetics of tumors of the nervous system [ M]. Lyon: IARC Press, 2000. 被引量:1
  • 4Loven D, Hardoff R, Sever ZB, et al. Nan-resectable slow growing meningiomas treated by hydroxyurea[ J]. J Neurooncol, 2004, 67(1 -2) :221 -226. 被引量:1
  • 5Al-Mefty O, Kadri PAS, Pravdenkova S, et al. Malignant progression in meningioma: Documentation of a series and analysis of cytogenetic findings[J]. J Neurosurg, 2004, 101 (2) : 210 -218. 被引量:1
  • 6Coke CC, Corn BW, Werner-Wasik M, et al. Atypical and malignant meningiomas: an outcome report of seventeen cases [ J]. J Neurooncol, 1998, 39( 1 ) :65 -70. 被引量:1
  • 7Bostrom J, Meyer-Puttlitz B, Wolter M, et al. Alterations of the tumor suppressor genes CDKN2A (p16 (INK4a)) , p14 (ARF) , CDKN2B (p15 (INK4b)) , and CDKN2C (p18 ([NK4c)) in atypical and anaplastic meningiomas [ J]. Am J Pathol, 2001,159 (2) :661 -669. 被引量:1
  • 8Perry A, Banerjee R, Lohse CM, et al. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas[ J]. Brain Pathol, 2002, 12 (2) :183 -190. 被引量:1
  • 9Bruna J, Brell M, Ferrer I, et al. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastie meningioma[J].Neuropathology, 2007, 27 (2) : 114 - 120. 被引量:1
  • 10Milosevic MF, Frost PJ, Laperriere N J, et al. Radiotherapy for atypical or malignant intracranial meningioma[ J]. Int J Radiat Oncol Biol Phys, 1996, 34(4) :817 -822. 被引量:1

二级参考文献8

  • 1Brat DJ,Scheithauer BW,Fuller GN,et al.Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system:angiocentric glioma,pilomyxoid astrocytoma and pituicytoma.Brain Pathol,2007,17(3):319. 被引量:1
  • 2Kleihues P,Burger PC,Scheithauer BW.The new WHO classification of brain tumours.Brain Pathol,1993,3 (3):255. 被引量:1
  • 3Daumas-Duport C,Varlet P.Dysembryoplastic neuroepithelial tumors.Rev Neurol (Paris),2003,159(6 -7Ptl):622. 被引量:1
  • 4Neder L,Colli BO,Machado HR,et al.MIB-1 labeling index in astrocytic tumors-clinicopathologic study.Clin Neuropathol,2004,23(6):262. 被引量:1
  • 5Fuller GN,Scheithauer BW.Symposium:The 2007 revised world health organization (WHO) Classification of tumors of the central nervous system:newly codified entities.Brain Pathol,2007,17(3):304. 被引量:1
  • 6Lois DN,Ohgaki H,Wiestler OD,et al.World organization classification of tumours of the central nervous system.Lyon:International Agency for Research on Cancer (IARC) Press,2007. 被引量:1
  • 7Kleihues P,Cavenee WK.Pathology and genetics of tumours of the nervous system.Lyon:International Agency for Research on Cancer (IARC) Press,2000.1 ~314. 被引量:1
  • 8Louis DN,Ohgaki H,Wiestler OD,et al.The 2007 WHO classification of tumours of the central nervous system.Acta Neuropathol,2007,114(2):97. 被引量:1

共引文献114

同被引文献76

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部